All treatments
Treatment
Diroximel fumarate (DRF) clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingNA
Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia
This study looks at a medicine called Diroximel Fumarate (DRF) for schizophrenia. Researchers want to see if DRF changes a brain chemical (glutathione) and helps with symptoms. It involves taking pills and having brain scans (MRI) over a few weeks.
For: Schizophrenia DisordersUnited Kingdom - Recruiting
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
This study looks at different approved medicines for Relapsing Multiple Sclerosis (RMS) in Germany. It observes patients already starting these treatments to see how they work in real-world settings over several years.
For: Relapsing Multiple SclerosisGermany